Recurrent Osteosarcoma: Clinical Trials

1 trial for Recurrent Osteosarcoma, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 terminated. 1 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 11Terminated 1

Follow Recurrent Osteosarcoma: new trials by email Literature Review of Recurrent Osteosarcoma trials Research Report on Recurrent Osteosarcoma

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Testing the Combination of Two Immunotherapy Drugs (Magrolimab and Dinutuximab) in Patients With Relapsed or Refractory Neuroblastoma or Relapsed Osteosarcoma
Biospecimen Collection, Bone Marrow Aspiration, Bone Marrow Biopsy - High Risk Neuroblastoma, Recurrent Neuroblastoma
Phase 1TerminatedNational Cancer Institute (NCI)122021-08-312026-06-30

Narrower conditions

Neuroblastoma (1)  ·  Osteosarcoma (1)

Broader conditions

Neoplasms (1)  ·  Neoplasms by Histologic Type (1)  ·  Neoplasms, Bone Tissue (1)  ·  Neoplasms, Connective Tissue (1)  ·  Neoplasms, Connective and Soft Tissue (1)  ·  Neoplasms, Germ Cell and Embryonal (1)  ·  Neoplasms, Glandular and Epithelial (1)  ·  Neoplasms, Nerve Tissue (1)  ·  Neoplasms, Neuroepithelial (1)  ·  Neuroectodermal Tumors (1)  ·  Neuroectodermal Tumors, Primitive (1)  ·  Neuroectodermal Tumors, Primitive, Peripheral (1)  ·  Sarcoma (1)

Interventions

Biopsy (1)  ·  Magnetic Resonance Spectroscopy (1)  ·  Specimen Handling (1)  ·  dinutuximab (1)  ·  magrolimab (1)

Sponsors

National Cancer Institute (NCI) (1)

Countries

Canada (1)  ·  United States (1)

Top investigators

Robbie G Majzner (1)

NIH funding

P30CA015704 (1), U01CA154967 (1), UM1CA228823 (1)